Analyzing the Relationship Between COVID-19 Susceptibility and Blood Group Variations: A Comprehensive Investigation into the Impact of ABO Blood Types on the Incidence, Severity, and Clinical Outcomes of the Disease

Abstract

Background: The covid-19 pandemic, originating from a new strain of coronavirus (SARS-CoV-2), is of concern to the global health arena as no crisis comparable to this has happened in the past. The investigation of not only the genetic components which may predispose for such a disease but also determine the severity of the illness has turned into a pressing research issue in modern days. Although it is desirable for the formulation of effective community health policy which provide tailor-made solutions concerning treatments, it is important that people have a clear understanding of the role played by blood type differences in this regard.

Methodology: The research was done at Baghdad Medical City Hospital during the period of June and August of 2021 using the patients with verified COVID-19 cases as their base. The data contained not only demographic information but also a blood type, disorder severity level, as well as the details were about the procedure. Various statistics organizations, include but not limited to the Pearson correlation, Chi-square and data visualization were applied using SPSS to establish the association between different blood types and the aftermath of COVID-19 infections. Results: The study demonstrated that among the many characteristics of COVID-19, blood types tested out to be assciating with a statistically significant number of them. Noteworthy is the significant negative association that connects blood types with the severity of the disease, and this factor also determines the period for recovery. It became clear that the recovery duration and the treatment response didn’t depend on age when the results were adjusted for any statistically insignificant variations that could be attributed to age. This evidences us that it is likely that the age factor is not considered as a premier factor in the progress of the COVID-19 in the analyzed patients. when goes to a green process, the human error disappears.

Conclusion: Obtained results of patients with diversified ABO blood types allowed us the data that confirmed disease incidence and severity can be modified during COVID-19. Given this fact, the doctors in the health care institutions and in the government agencies responsible for public health should gain this information. Also, the organizations need this information to develop a disease prevention and control policy. In a wider plan of the research and response strategy to the pandemic, COVID-19, the results reveal that on the genetic side the blood type must be borne in mind, amongst other hereditary features.